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Abstract:  
Introduction: Topical drug administration is simplest and easiest route of localized drug delivery anywhere in the 
body by routes as ophthalmic, rectal, vaginal and skin. These are applied as wide spectrum of preparations in case 
of both cosmetic and dermatological, to the healthy or diseased skin. Drugs are administered topically for their 
action at the site of application or for systemic effects. Clindamycin is a lincosamide antibiotic. It is usually used to 
treat infections with anaerobic bacteria, but can also be used to treat some protozoal diseases, such as malaria. It is 
a common topical treatment for acne and can be useful against some methicillin-resistant Staphylococcus aureus 
(MRSA) infections.  
Objective and aim: The aim of present study was to develop an emulgel formulation of clindamycin phosphate using 
Carbopol 934 or HPMC 2930 as a gelling agent. The influence of the type of gelling agent and the concentration of 
both the oil phase and emulsifying agent on the release of the drug and its microbial activity were investigate using 
23 factorial design in addition, rheological properties were also evaluated. 
Conclusion: The present work is to develop Clindamycin emulgel adaptable topical drug delivery systems which 
provide protection against oxidation, fast absorption, prolonged release and enables reduction in dose and evaluate 
the emulgel using an ideal topical drug candidate of Clindamycin by suitable method with its release. 
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INTRODUCTION:  
Topical drug administration is simplest and easiest 
route of localized drug delivery anywhere in the body 
by routes as ophthalmic, rectal, vaginal and skin. 
These are applied as wide spectrum of preparations in 
case of both cosmetic and dermatological, to the 
healthy or diseased skin [1]. Drugs are administered 
topically for their action at the site of application or 
for systemic effects [2]. Drug absorption is enhanced 
through the skin if the drug substance is in solution, if 
it has a favourable lipid/water partition coefficient 
and if it is a non electrolyte. Mostly, pharmaceutical 
preparations applied to the skin are expected to serve 
some local action and are formulated to provide 
prolonged local contact with minimal systemic drug 
absorption. Drugs applied to the skin for their local 
action include antiseptics, antifungal agent, skin 
emollients and protectants. Topical delivery system 
proves beneficial by passing first pass metabolism. 
Avoidance of the risks and inconveniences of 
intravenous therapy and of the varied conditions of 
absorption like pH changes, presence of enzymes, 
gastric emptying time are other advantages of topical 
preparations [3, 4]. The topical drug delivery system 
allows its usage where the others system of drug 
administration fails or it is mainly used in fungal 
infection. 
Human skin is a uniquely engineered organ that 
permits terrestrial life by regulating heat and water 
loss from the body whilst preventing the ingress of 
noxious chemicals or microorganisms Fig. 1 [2]. 
 
Fig. 1: Cross section of Skin 
 
MATERIALS AND METHODS: 
Clindamycin phosphate was kindly provided by 
curetech skin formulation Baddi, Himanchal Pradesh, 
carbpol 934 (shree Chemicals new Delhi, 
Hydroxypropyl methyl cellulose, (HPMC 2910) was 
kindly supplied by atlis pharmaceuticals Baddi 
Himanchal Pradesh. Tween 20, Span 20, methyl and 
propyl parabens, light liquid paraffin, propylene 
glycol, Dimethyl Formamide (DMF), hydrochloric 
acid and ethyl alcohol were purchased from innova 
pharmaceutical chemicals (Chandigarh, Punjab). 
Triethanolamine (TEA) was supplied from innova 
pharmaceutical chemicals (Chandigarh, Punjab). 
Cellulose membrane (M. Wt. cutoff 10-000-14-1000) 
was supplied from Sigma Chemical Company (Saint 
Louis, MO). C. albicans ATCC NO10231 was kindly 
provided by the Department of Microbiology, 
October University for Science and Modern Arts 
(MSA) clinical isolate growth at 250c for 24 hours on 
Sabouraud’s agar.  
OBJECTIVE: The objective of preformulation 
testing is to generate information useful to the 
formulator in developing stable and bioavailable 
dosage forms. Following preformulation studies are 
carried out:- 
Physical appearance 
Identification of drug. 
IR spectra of drug sample. 
Solubility studies. 
Physical Appearance: 
The prepared Clotrimazole emulgel erwe inspected 
visually of their colour, homogeneity consistency and 
pH. The pH values of 1% aqueous solutions of the 
prepared emulgel were measured by a pH meter. 
Experiments were carried out in triplicate. 
Identification of Drug: 
Clindamycin phosphate was kindly provided by 
curetech skin formulation Baddi, Himanchal Pradesh, 
carbpol 934 (shree Chemicals New Delhi, 
Hydroxypropyl methyl cellulose, (HPMC 2910) was 
kindly supplied by atlis pharmaceuticals Baddi 
Himanchal Pradesh. identified and characterized as 
per requirement of official standards. Clindamycin 
phosphate was identified by ultraviolet spectroscopy. 
Drug excipient interaction study (FTIR spectra): 
Drug Excipient Interaction Study was carried out to 
check the interaction between the drug and excipient 
by using FT-IR spectrophotometer (Perkin-Elmer, 
Model-1600, USA). Accurately weigh 50 mg each of 
Clindamycin phosphate, Carbopol-934, Carbopol-
940, HPMC-5 and HPMC-15. The mixtures of 
Clindamycin phosphate & Carbopol-934, 
Clindamycin phosphate & Carbopol-940, 
Clindamycin phosphate & HPMC-5, Clindamycin 
phosphate & HPMC-15 were placed separately on the 
sampling plate of FT-IR spectrophotometer. Then 
scanning of the sample was performed and IR spectra 
were obtained as shown in Fig, 2, 3, 4, 5 and 6 
respectively. The data of the interaction study is 
shown in Table 1. 
IAJPS 2017, 4 (11), 4071-4077                     Saurabh Gupta et al                      ISSN 2349-7750 
 
w w w . i a j p s . c o m  
 
Page 4073 
 
Fig. 2: FTIR Spectra of Clindamycin phosphate 
 
Fig. 3: FTIR Sprectra of mixture of Clindamycin phosphate and Carbopol-934 
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Fig. 4: FTIR Sprectra of mixture of Clindamycin phosphate and Carbopol-940 
 
Fig. 5: FTIR Sprectra of mixture of Clindamycin phosphate and HPMC-5 
 
Fig. 6: FTIR Sprectra of mixture of Clindamycin phosphate and HPMC-15 
 
Table 1: Comparison between Peaks Obtained In Drug and Drug-Polymer Mixture 
S. 
no. 
 
Peaks Obtained 
in drug 
(frequency cm-1) 
 
Description 
 
Peak obtained 
in mixture of 
drug and 
Carbopol-934 
 
Peak obtained 
in mixture of 
drug and 
Carbopol-940 
 
Peak 
obtained in 
mixture of 
drug and 
HPMC-5 
Peak 
obtained in 
mixture of 
drug and 
HPMC-15 
1 788 C-H (Aromatics 791 790 788 788 
2 1059 C-N (Amine) 1058 1058 1059 1059 
3 1258 C-O 1254 1256 1258 1257 
4 1457 C-O-H bonding 1454 1454 1465 1458 
5 2929 C=C (stretch) 2931 2930 2929 2929 
6 2960 C=C (stretch) 2960 2959 2959 2959 
7 3401 N-H (stretch) 3427 3414 3499 3404 
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Solubility Studies: 
It affects the bioavailability of drug, the rate of drug 
release into dissolution medium and consequently, 
the therapeutic efficacy of pharmaceutical product. 
The solubility of the molecules in various solvent is 
determined as the first step. This information is 
valuable in developing a formulation. The solubility 
of material is usually determined by the equilibrium 
solubility method, which employs a saturated 
solution of the material, obtained by stirring an 
excess of material in the solvent for a prolonged until 
equilibrium obtained. 
Clindaycin phosphate are soluble in: 
 
Methanol 
Ethanol 
Dimethyl sulfoxide 
 
Evaluation: 
Drug Content Determination: 
Weigh accurately 1 gm of Emulgel and it was 
dissolved in 100 ml of methanol. The volumetric 
flask was kept for 2 hours and shaken well in a 
shaker to mix it properly. The solution was passed 
through the filter paper and filtered. The absorbance 
was measured spectrophotometrically at 210 nm after 
appropriate dilution against corresponding Emulgel 
concentration as blank. The drug content was 
determined using following formula. The results have 
been reported in Fig. 7.  
Drug content = (concentration × dilution factor × volume taken) × conversion factor 
 
Fig. 7: Percentage drug content of different formulations F1-F12 
.
 
Fig. 8: Viscosity of different formulations F1- F12 
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Fig. 9: pH of different formulations F1-F12 
pH Determination:  
The pH of Emulgel formulations was determined by 
using digital pH meter. One gram of gel was 
dissolved in 100 ml of distilled water and it was 
placed for two hours. The measurement of pH of 
each formulation was done in triplicate and average 
values were calculated. The pH of the Emulgel 
formulations was in range of 5.5 ± 0.54 to 6.4 ± 0.43, 
which lies in the normal pH range of the skin and 
would not produce any skin irritation. There was no 
significant change in pH values as a function of time 
for all formulations. The data is reported in Fig. 9. 
Measurement of Viscosity: 
The viscosity of the formulated batches was 
determined using a Brookfield Viscometer (RVDV-1 
Prime, Brookfield Engineering Laboratories, USA) 
with spindle 07. The formulation whose viscosity 
was to be determined was added to the beaker and 
was allowed to settle down for 30 min. at the assay 
temperature (25° ± 1°C) before the measurement was 
taken. Spindle was lowered perpendicularly in to the 
centre of the Emugel, taking care that spindle does 
not touch the bottom of the beaker and rotated at a 
speed of 50 rpm for 10 min. The viscosity reading 
was noted down. The average of three readings was 
taken in 10 minutes was noted as the viscosity of 
Emulgel. The viscosity of the formulations increases 
as the concentration of polymer increases. The data is 
reported in Fig. 8 
 
RESULT: 
The purity of the drug carried out by FTIR spectrum 
of the drug sample, which is in agreement with 
standard IR spectrum of Clindamycin. The FTIR 
spectrum of drug sample has been shown in Fig. 2. 
The physical and chemical interaction between drug 
and the excipients were studied using FTIR 
technique. No significant shifts in the peaks 
corresponding to the drug or the polymer were 
observed as shown in Table 1. It has been observed 
that there is no chemical interaction between the 
Clindamycin phosphate and the polymers used. 
Hence, there was no interaction between the drug and 
the polymers. So they can be successfully 
incorporated in the Emulgel. The FTIR spectrums of 
the drug and polymers are shown in Fig. 3, 4, 5 and 6 
respectively. 
The solubility of material is usually determined by 
the equilibrium solubility method, Clindaycin 
phosphates are soluble in Methanol, Ethanol and 
Dimethyl sulfoxide. 
The drug content was determined for all the 
formulations by UV spectrophotometer method. The 
result of the drug content varies between 77.50 % and 
93.30% as shown in Fig. 7. The results indicated that 
the drug dispensed uniformly throughout the 
Emulgel.  
The viscosity of the formulation batches were 
checked by using Brookfield viscometer. The results 
are shown in Fig. 8. According to the results, the 
viscosity differs in accordance to the concentration of 
the gelling agent used in different formulations. From 
the data it has been revealed that the formulations 
with Carbopol-934, Carbopol-940 are more viscous 
than those with HPMC-5 and HPMC-15 gelling 
agents. 
The pH of the Emulgel formulation was in the range 
5.3 ± 0.5 to 6.2 ± 0.5, which lies in the normal pH 
range of the skin and would not produce any skin 
irritation. The results are shown in Fig. 9.  
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CONCLUSION: 
Acne vulgaris is a common skin disease of 
pilosebaceous unit that affects 85% to 100% of 
people mostly affecting face. Severest form occurs in 
boys but it tends to persist longer in girls. The 
incidence peaks at teenage but also affects men and 
women between 20-40 years of age. Patients often 
have problems with self-esteem, self-confidence, 
social withdrawal, depression, anger and higher 
unemployment rate. Morbidity in acne is primarily 
emotional. If left untreated it leaves physical and 
emotional scar that can be devastating. There are 
many drugs that can be used in the treatment of acne, 
some of them are; Antibiotics (tetracycline, 
Doxycycline, Minocycline, Clindamycin, 
Erythromycin, Clarithromycin), Retinoids (tretinoin, 
isotretinoin), Benzoyl peroxide and miscellaneous. 
Clindamycin is a lincosamide antibiotic. It is usually 
used to treat infections with anaerobic bacteria, but 
can also be used to treat some protozoal diseases, 
such as malaria. It is a common topical treatment for 
acne and can be useful against some methicillin-
resistant Staphylococcus aureus (MRSA) infections. 
The present work is to develop Clindamycin emulgel 
adaptable topical drug delivery systems which 
provide protection against oxidation, fast absorption, 
and prolonged release and enables reduction in dose 
and evaluate the emulgel using an ideal topical drug 
candidate of Clindamycin by suitable method with its 
release. 
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